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SYNOPSIS: 
 
In a large cohort of patient with X-linked retinoschisis, peripheral schisis was associated 
with vitreous hemorrhage and retinal detachment.  Each additional peripheral fundus 
abnormality increased the odds of retinal detachment by a factor of 4.06.   
 
 
 ABSTRACT 
 
Background/Aims:  Vitreous hemorrhage (VH) and retinal detachment (RD) cause a 
precipitous decline in vision in a subset of patients with X-linked retinoschisis (XLRS), 
an otherwise a slowly progressive condition.  This study aims to report the frequency of 
macular and peripheral retinal findings in a large cohort of X-linked retinoschisis (XLRS) 
patients and to determine whether peripheral retinal findings are associated with VH 
and RD.   
 
Methods: A retrospective observational case series was performed with 65 patients 
with XLRS with a pathogenic variant in RS1. Chart review included examination notes, 
fundus photographs, and optical coherence tomography (OCT).  Fisher exact tests and 
univariable logistic regression analysis were used to determine the association between 
peripheral retinal findings (including retinoschisis, metallic sheen, vascular sheathing, 
pigmentary changes, white spiculations, and vitreous veils) and complications (including 
VH and RD).   
 
Results: Seven eyes (8%) showed normal macular structure on OCT.  Peripheral 
retinoschisis was significantly associated with both VH and RD.  Out of 10 eyes with 
complications, 9 (90%) had peripheral retinoschisis, compared with 33 out of 116 eyes 
(28%) without complications (p=0.0014).  In addition, each additional peripheral finding 
increased the odds of RD by a factor of 4.06 (95% CI 1.58-10.39, p=0.028).  There were 
no complications in the 28 eyes with a normal periphery (p=0.84) or in the 35 eyes with 
metallic sheen (p=0.42).   
 
Conclusion:  The data suggest that patients with peripheral retinoschisis are at 
increased risk for VH and RD.  Furthermore, patients with additional peripheral retinal 
findings together with peripheral schisis may carry additional risk for RD. 
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INTRODUCTION 
 
X-linked retinoschisis (XLRS) is an inherited retinal degeneration presenting in the first 
decade of life and characterized by a splitting of the inner retina in the macula with 
cystic cavities.  Approximately 50% of individuals have schisis cavities in the peripheral 
retina as well1.  Other peripheral retinal findings may include metallic sheen, retinal 
pigment epithelium (RPE) pigmentary changes, white spiculations, vascular sheathing, 
and vitreous veils1.  The natural history is variable, with some patients experiencing 
deterioration in the first and second decade (20/60 to 20/120), whilst others remain 
relatively stable in childhood; further deterioration can occur later in adulthood 
secondary to outer retinal atrophy2.  Patients are at increased risk for vitreous 
hemorrhage and retinal detachment, and these two complications primarily account for 
severe visual deterioration at a younger age in affected patients.  Retinal detachments 
are typically rhegmatogenous, caused by breaks in the inner and outer walls of the 
schisis cavity, but tractional detachments can also occur.  Vitreous hemorrhage is 
thought to occur in association with retinal breaks and vitreoretinal traction.   
 
XLRS is caused by mutation in retinoschisin 1 (RS1), which has a discoidin domain and 
is implicated in cell-cell adhesion, consistent with the phenotype of schisis in the setting 
of RS1 mutations3.  RS1 is expressed in photoreceptors, but the protein is present in 
both the outer and inner retina4.   
 
Given the potentially devastating visual consequences of vitreous hemorrhage and 
retinal detachment, a clinically relevant question is whether peripheral retinal findings 
are associated with these complications.  It is biologically plausible that peripheral 
schisis would predispose patients, and other peripheral retinal changes may play a role 
as well.  Others have noted peripheral schisis in patients with vitreous hemorrhage5 and 
retinal detachment6, although prior reports lack statistical analysis.  We hypothesize that 
peripheral schisis and other peripheral retinal changes are associated with an increased 
risk of vitreous hemorrhage and retinal detachment in XLRS patients.  This question 
was addressed with a retrospective chart review of 65 patients with molecularly-proven 
XLRS. 
 
METHODS 
 
Patients 
This was a retrospective review of medical records of all patients seen at Moorfields 
Eye Hospital with XLRS, diagnosed based on clinical findings and family history, and 
confirmed by detection of a disease-causing variant in RS1.  Patients without fundus 
photos on record were excluded.  In total 65 patients were ascertained, with visit dates 
between 1965 and 2015, and follow-up ranging from a single encounter to 48 years.  
Although some patients had visit dates as far back as 1965, all patients had visit dates 
recent enough to have genetic testing.  Ethical approval was obtained from Moorfields 
Eye Hospital for this retrospective observational series. 
 
Clinical Evaluation 
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All patients had undergone a comprehensive ophthalmologic examination, including 
measurement of best-corrected visual acuity, intraocular pressure, slit-lamp 
examination, dilated fundus examination, color fundus photography, and spectral-
domain optical coherence tomography (SD-OCT).  In addition, a proportion of patients 
had measurement of color vision, kinetic visual field, and electrophysiology.    
 
Color fundus photography was performed with a TRC-50IA retinal fundus camera 
(Topcon, Tokyo, Japan) or an Optos ultra widefield camera (Optos plc, Scotland, UK).  
Spectral domain OCT was performed with the Spectralis OCT (Heidelberg Engineering, 
Heidelberg, Germany).  Electrophysiology included full-field electroretinogram (ffERG) 
and pattern ERG (pERG), recorded with gold foil electrodes.  Protocols incorporated the 
recommendations of the International Society for Clinical Electrophysiology of Vision7 8. 
 
The main outcome measures were the frequency of peripheral retinal findings, including 
retinoschisis, metallic sheen, vascular sheathing, pigmentary changes, white 
spiculations, and vitreous veils; and frequency of complications, including vitreous 
hemorrhage and retinal detachment. 
 
Statistics 
Fisher exact tests were performed on the 2x2 cross-tabulations of peripheral retinal 
findings and complications, with a correction for multiple testing for 7 repeat tests (one 
for each peripheral finding, including a “normal” periphery).  P-values were adjusted 
based on the multiple-testing correction.  Univariable logistic regressions were 
performed to test the effect of multiple peripheral findings on odds of complications.  
Fisher exact tests were performed on the cross-tabulations of genotype and peripheral 
retinal findings, with a correction for multiple testing for 210 repeat tests (35 genotypes x 
6 peripheral retinal findings).   P-values were adjusted based on the multiple-testing 
correction.   
 
RESULTS 
 
Patients and Clinical Findings 
Sixty-five patients with molecularly-proven X-linked retinoschisis seen between 1965 
and 2015 were included.  They ranged in age from 3 to 65 years.  Best-corrected visual 
acuity ranged from 6/9 to no perception of light.  Color vision was documented in only 4 
patients, ranging from 0/17 color plates to 15/17.  Full-field ERGs, documented in 16 
patients, ranged from normal (one patient) to rod or rod-cone abnormalities with an 
electronegative waveform.  Pattern ERGs, documented in 8 patients, were variably 
reduced. 
 
RS1 Sequence Variants 
Thirty-six different RS1 likely disease-causing variants were identified, including 2 large 
deletions, 3 single nucleotide deletion/duplications, 3 splice site mutations, 1 nonsense 
mutation, and 27 missense mutations.  Thirty mutations were previously reported (29 in 
the literature and 1 in the Leiden Open Variation Database)9-19(Table 1).   
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Table 1.  Mutations in XLRS Cohort 
Six mutations were novel.  
None of the novel mutations 
are found in the Exome 
Aggregation Consortium20, 
and all are predicted 
“probably damaging” using 
Polyphen-221.   
 
 
Macular Phenotype 
Ninety eyes in 47 patients had 
macular SD-OCT.  Sixty-eight 
eyes (76%) showed macular 
schisis on SD-OCT, ranging 
in age from 5 to 36.  Thirty-
five eyes (39%) showed outer 
retinal atrophy, ranging in age 
from 29 to 64.  Twenty eyes 
(22%) showed both macular 
schisis and outer retinal 
atrophy, ranging in age from 
33 to 64.  Seven eyes (8%) in 
4 patients showed no schisis 
or atrophy, ranging in age 
from 11 to 45.  The 45 year-
old was an outlier, with the 
other patients ranging from 11 
to 20 years of age.  All 7 eyes 
with a normal macula had 
peripheral retinal 
abnormalities. Four eyes had 
pigmentary changes, three 
eyes had peripheral schisis, 2  
All variant positions are specified with respect to 
Ensembl transcript ENST0000037998422.  # pts= 
number of patients.                                                    
 
eyes had white spiculations, and 2 eyes had metallic sheen.  All 8 patients had 
missense mutations in RS1.  Out of the 43 patients that had SD-OCT in both eyes, 40 
patients (93%) had concordant phenotypes in the two eyes, while 3 patients (7%) had 
discordant phenotypes. 
 
Peripheral Retinal Phenotype 
There were 126 eyes with fundus photos.  Twenty-eight (24%) had a normal peripheral 
retina.  Peripheral retinal findings, from most to least common, included retinoschisis in 
Mutation # pts Previous Report 
Deletion of exon 1 1 Retinoschisis Consortium7 
c.35T>A (p.Leu12His) 2 Retinoschisis Consortium7 
c.52+2T>C 1 Khan et al.8 
Deletion of exons 2 and 3 1 Khan et al.8 
c.120C>A (p.Cys40X) 1 Retinoschisis Consortium7 
c.185-1G>A  1 Vincent et al.9 
c.184+2T>G 1 Vincent et al.9 
c.214G>A (p.Glu72Lys) 3 Retinoschisis Consortium7 
c.214G>C (p.Glu72Gln) 2 Yu et al.10 
c.239A>C (p.Gln80Pro) 1 Novel 
c.242T>A (p.Ile81Asn) 1 Simonelli et al.11 
c.276G>C (p.Trp92Cys) 1 Hotta et al.12 
c.304C>T (p.Arg102Trp) 6 Retinoschisis Consortium7 
c.305G>A (p.Arg102Gln) 5 Retinoschisis Consortium7 
c.317A>C (p.Gln106Pro) 1 Novel 
c.325G>C (G109R)  1 Sauer et al.13 
c.325G>T (p.G109W) 1 Sergeev et al.14 
c.326G>C (p.Gly109Ala) 1 LOVD17 
c.329G>A (p.Cys110Tyr) 2 Retinoschisis Consortium7 
c.337C>T (p.Leu113Phe) 1 Retinoschisis Consortium7 
c.378delT (p.Leu127Ter) 1 Novel 
c.421C>T (p.R141C) 3 Retinoschisis Consortium7 
c.435dupT (p.Glu146fs) 1 Novel 
c.496T>C (p.Tyr166His) 1 Chen et al.15 
c.508A>C (p.Thr170Pro) 1 Novel 
c.526T>C (p.Phe176Val) 1 Novel 
c.554C>A (p.Thr185Lys) 2 Sergeev et al.14 
c.574C>T (p.Pro192Ser) 5 Retinoschisis Consortium7 
c.575C>T (p.Pro192Leu) 1 Lesch et al.16 
c.579dupC (p.Ile194fs) 3 Retinoschisis Consortium7 
c.589C>T (p.Arg197Cys) 1 Retinoschisis Consortium7 
c.596T>C (p.Ile199Thr) 1 Retinoschisis Consortium7 
c.598C>T (p.Arg200Cys) 4 Retinoschisis Consortium7 
c.599G>A (p.Arg200His) 1 Retinoschisis Consortium7 
c.608C>T (p.P203L) 1 Retinoschisis Consortium7 
c.637C>T (p.Arg213Trp) 2 Retinoschisis Consortium7 
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42 eyes (33%), metallic sheen in 35 eyes (28%), vitreous veils in 24 eyes (19%), RPE 
pigment migration in 20 eyes (16%), white spiculations in 11 eyes (9%), and vascular 
sheathing in 8 eyes (6%) (Table 2).  Representative fundus photos of relevant 
peripheral retinal findings are shown in Figure 1.   
 
Table 2.  Frequency of peripheral retinal findings and complications of vitreous hemorrhage 
and retinal detachment in XLRS cohort 
 All Eyes VH or RD VH RD RRD TRD ExRD 
Total 126 10  (7.9) 4 (3.2) 8 (6.3) 4 3 1 
Normal Periphery 28 (24.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Vitreous Veils 24 (19.0) 2 (20.0) 0 (0.0) 2 (25.0) 1 (25.0) 1 (33.3) 0 (0.0) 
Sheen 35 (27.8) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Schisis 42 (33.3) 9 (90.0) 4 (100.0) 7 (87.5) 4 (100.0) 2 (66.7) 1 (100.0) 
White Spiculations 11 (8.7) 2 (20.0) 0 (0.0) 2 (25.0) 2 (50.0) 0 (0.0) 0 (0.0) 
Vascular Sheathing 8 (6.3) 1 (10.0) 0 (0.0) 1 (12.5) 0 (0.0) 0 (0.0) 1 (100.0) 
Pigment 20 (15.9) 4 (40.0) 1 (25.0) 4 (50.0) 2 (50.0) 1 (33.3) 1 (100.0) 
 
VH= vitreous hemorrhage.  RD= retinal detachment.  RRD= rhegmatogenous retinal 
detachment.  TRD= tractional retinal detachment.  ExRD= exudative retinal detachment.  
Values are shown as number of eyes (with percentage of the total in parenthesis). 
 
 
Genotype-Phenotype Correlations 
All peripheral findings were compared across genotypes to define genotype-phenotype 
correlations.  All 6 eyes in all 3 patients with the c.214G>A(p.Glu72Lys) mutation had 
vitreous veils, which was statistically significant (p=0.021).  The 2 most common 
mutations, c.304C>T(Arg102Trp) and c.305G>A(Arg102Gln), showed 8 out of 12 eyes 
with peripheral metallic sheen and 3 out of 10 eyes with peripheral white spiculations, 
respectively.  However, this did not reach statistical significance. 
 
Complications 
Occurrences of vitreous hemorrhages and retinal detachments were determined by 
documentation in the patient notes, and were corroborated by fundus photos when 
available.  There were 4 eyes with vitreous hemorrhage (3%) and 8 eyes with retinal 
detachment (6%) (Table 2).  There were no retinal detachments or vitreous 
hemorrhages in eyes with a normal peripheral retinal exam (p=0.84), or in eyes with 
metallic sheen (p=0.42)(Table 3).   
 
Out of 10 eyes with complications, 9 (90%) had peripheral retinoschisis, compared with 
only 28% of eyes without complications (p=0.0014).  This includes 4 out of 4 eyes with 
vitreous hemorrhage (p=0.07) and 7 out of 8 eyes with retinal detachment (p=0.014) 
that showed peripheral schisis (Table 3).  In addition, the number of peripheral findings 
was significantly associated with the odds of retinal detachment, with each additional 
peripheral finding increasing a patient’s odds of detachment by a factor of 4.06 (95% CI 
1.58-10.39, p=0.028).  There was no similar effect on the odds of vitreous hemorrhage. 
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Table 3.  Peripheral retinoschisis is significantly associated with complications. 
  
  Any Complication Vitreous Hemorrhage Retinal Detachment 
  No Yes 
p-
value 
No Yes 
p-
value 
No Yes 
p-
value 
 Total 116 10  122 4  118 8  
Peripheral 
Schisis 
No 
83 
(71.6) 
1 (10.0) 
0.0014 
84 
(68.9) 
0 (0.0) 
0.07 
83 
(70.3) 
1 (12.5) 
0.014 
Yes 
33 
(28.4) 
9 (90.0) 
38 
(31.1) 
4 
(100.0) 
35 
(29.7) 
7 (87.5) 
Normal 
Periphery 
No 
88 
(75.9) 
10 
(100.0) 
0.84 
94 
(77.0) 
4 
(100.0) 
1.00 
90 
(76.3) 
8 
(100.0) 
1.00 
Yes 
28 
(24.1) 
0  
(0.0) 
28 
(23.0) 
0 
(0.0) 
28 
(23.7) 
0  
(0.0) 
Peripheral 
Sheen 
No 
81 
(69.8) 
10 
(100.0) 
0.42 
87 
(71.3) 
4 
(100.0) 
1.00 
83 
(70.3) 
8 
(100.0) 
0.70 
Yes 
35 
(30.2) 
0  
(0.0) 
35 
(28.7) 
0  
(0.0) 
35 
(29.7) 
0 
(0.0) 
 
Values are shown as number of eyes (with percentage of the total in parenthesis).  
Significant p-values are in bold. 
 
 
DISCUSSION 
 
The natural history of XLRS is highly variable, but if there is progression it is often very 
slow in childhood and early adulthood, potentially followed by additional gradual decline 
in later adulthood from macular atrophy.  This chronic clinical course can be interrupted 
by a precipitous drop in vision due to complications of vitreous hemorrhage or retinal 
detachment, often at a young age.  This study describes the frequency of these 
complications in a cohort of 65 patients from a single center with molecularly-proven 
XLRS, as well as the frequency of peripheral retinal findings.  The study is limited by the 
small sample size, the retrospective design, and the widely variable follow-up of 
subjects. 
 
We report macular schisis in 76% of eyes in our cohort.  Previous reports in the 
literature range from 68% to 100%1 5 6 23.  The age distribution in the cohort is expected 
to significantly impact the prevalence of macular schisis, since the natural history of 
disease is macular schisis followed by macular atrophy and resolution of schisis.  
Therefore, clinicians typically view macular atrophy as a presumptive sign of prior 
schisis. George et al. and Kellner et al. report macular schisis in 68% and 71% of eyes 
respectively, but both report that 100% of eyes showed macular pathology on 
examination, in the form of schisis, blunted fovea, pigment irregularities, or RPE 
atrophy1 6.  In contrast, we report 7 eyes in 4 patients with normal macular structure on 
SD-OCT (8% of eyes).  The previous reports, with the exception of Wang et al., were 
published before the RS1 gene was identified and the diagnosis was therefore based on 
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clinical examination and family history, with family linkage to the XLRS locus in the case 
of George et al.   In the current study the molecular diagnosis was confirmed in all 
patients, thus allowing identification of patients with a normal macula despite a 
pathologic RS1 variant.  However, this may not fully explain the discrepancy as all 7 
eyes had peripheral retina abnormalities and perhaps would have been classified as 
XLRS even without genetic testing in the setting of a consistent family history.  Previous 
investigations into genotype-phenotype correlations have found that patients with 
normal macular structure nearly always have missense mutations, although the inverse 
is not true: patients with those same missense mutations can have macular schisis and 
variable severity11.  This is consistent with our data.  All 4 patients with normal macular 
structure had missense mutations. In 3 out of 4 cases there were other patients with the 
same mutations that did show macular schisis.  In the fourth case, there were 
discordant phenotypes between the 2 eyes: one eye had a normal macula with 
peripheral schisis, while the other eye had macular schisis, vitreous hemorrhage, and 
retinal detachment.  Prior genotype-phenotype investigations have also revealed worse 
visual acuity and more frequent ERG abnormalities among patients with nonsense, 
splice-site, and frame-shift mutations compared to those with missense mutations11. It is 
well established that an electronegative bright flash dark-adapted ERG is a 
characteristic finding in XLRS, although it is not universal.  The b-wave amplitude is 
variable and the a-wave amplitude can also be reduced, especially in those with 
significant peripheral retinoschisis or pigmentary changes11.  Despite the large test-
retest variability of ERG recordings and the inherent limitations associated with ERG 
assessment in children (important given the majority of complications are in childhood), 
future prospective studies of bright flash dark adapted a- and b-wave amplitudes in 
relation to vitreous hemorrhage or retinal detachment may suggest these parameters as 
a functional marker for risk of complication.  
 
We report 33% of eyes with peripheral retinoschisis, which is lower than previous 
reports, which have ranged from 43-60%1 5 23 24.  Similar to macular schisis, the rate of 
peripheral schisis may also be impacted by the age distribution of the cohort, since 
schisis cavities sometimes reabsorb with time.  The rates of other peripheral findings 
have been reported in George et al. (56 patients), in which reported rates were 
generally higher than the rates reported herein: metallic sheen in 38% of eyes (vs. 
28%), vitreous veils in 39% of eyes (vs. 19%), pigmentary changes in 29% of eyes (vs. 
16%), white spiculations in 11% of eyes (vs. 9%), and vascular sheathing in 9% of eyes 
(vs. 6%)1.  The complication rates reported here are also on the lower end of the range 
previously reported.  We report vitreous hemorrhage in 3% of eyes, compared to 4-21% 
in previous reports, and retinal detachment in 6% of eyes, compared to 5.5-16% in 
previous reports1 5 6 24.   
 
We report here that the presence of peripheral retinoschisis is significantly associated 
with the complications of vitreous hemorrhage and retinal detachment, and furthermore 
that the odds of retinal detachment increase significantly with each additional peripheral 
retinal abnormality.  In addition, there were no complications in eyes with a normal 
periphery or with metallic sheen, although this did not reach statistical significance.  
There was one patient with a complication (RD) and no peripheral schisis, although we 
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cannot rule out that he had a previous schisis cavity that spontaneously reabsorbed.  
Kellner et al. propose that peripheral schisis is a risk factor for retinal detachment 
because peripheral schisis was present in 75% of fellow eyes in cases of retinal 
detachment, compared to 53% of all eyes without a history of retinal detachment6.  
More recently, Wang et al. reported vitreous hemorrhage in 4 out of 23 patients with 
XLRS, and all 4 had peripheral retinoschisis5.  This study adds to the previous reports, 
which lack statistical analysis, by demonstrating a statistically significant association 
between peripheral schisis and complication rates, as well as an increasing likelihood of 
retinal detachment with each additional peripheral fundus finding.  A clinically relevant 
question is whether these peripheral retinal findings precede the complications or 
appear subsequently as a result of the complications.  Of note, these complications 
frequently happen in childhood and adolescence.  Sometimes patients initially present 
with vitreous hemorrhage or retinal detachment, and no prior records exist.  Kellner et 
al. report that all vitreous hemorrhages in their cohort occurred before the age of 10, 
and most retinal detachments occurred before the age of 11, with the exception of some 
longstanding detachments of unknown duration found later in life6.  Patients in our 
cohort also presented with complications at a young age.  Patients with vitreous 
hemorrhage ranged from 8 to 21 years old, and patients with retinal detachment ranged 
from 3 to 21 years old, plus one 28 year-old with an old retinal detachment of unknown 
duration.  Unfortunately in most cases there were no records prior to the complication, 
with 2 exceptions.  In one case a patient had an exudative retinal detachment at 21 
years of age with previous documentation of vitreous veils in that eye at age 9 and 
peripheral schisis at age 14.  Another patient had vitreous hemorrhage at age 11 and a 
tractional retinal detachment at age 12 with previously documented peripheral schisis 
and pigmentary changes in the same eye at age 5.  This demonstrates that at least in 
these cases the peripheral retinal findings preceded the complications.  Furthermore, 
despite having numerous eyes with a normal periphery, we have no documented cases 
of a patient with normal periphery developing a subsequent complication.  Finally, the 
presence of these peripheral retinal findings in large numbers of XLRS patients without 
complications argues that these findings are not a consequence of prior vitreous 
hemorrhage or retinal detachment. However, we cannot exclude that a patient may 
have had a vitreous hemorrhage that resolved without presenting to the 
ophthalmologist. 
 
This study reports the frequency of both macular and peripheral retinal findings in a 
large cohort of molecularly proven XLRS patients.  The data suggest that patients with 
peripheral retinoschisis are at increased risk for vitreous hemorrhage and retinal 
detachment.  Furthermore, patients with additional peripheral retinal findings together 
with peripheral schisis may carry additional risk for retinal detachment.  A normal retinal 
periphery and a retinal metallic sheen may both portend a good prognosis with respect 
to risk for complications. 
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